Monte Rosa Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Jan 9, 2026
Filed with the SEC on Jan 9, 2026 and accepted by EDGAR at Jan 9, 2026, 16:19 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001193125-26-008951. Last ingested by Listed: Nov 5, 2026, 11:59 ET. Listed shows no prices and gives no investment advice.